Amanote Research
Register
Sign In
Systematic Review With Meta-Analysis: The Efficacy and Safety of CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Α Agent (Infliximab), in Inflammatory Bowel Diseases
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.13990
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
February 26, 2017
Authors
Y. Komaki
A. Yamada
F. Komaki
D. Micic
A. Ido
A. Sakuraba
Publisher
Wiley
Related search
Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Pgi9 - Systematic Review and Meta-Analysis of the Efficacy of Infliximab Biosimilars in Inflammatory Bowel Disease Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
THU0218 the Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results From the Turkbio Registry
Review Article: Consensus Statements on Therapeutic Drug Monitoring of Anti-Tumour Necrosis Factor Therapy in Inflammatory Bowel Diseases
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Angiology
Cardiovascular Medicine
Cardiology
Pregnancy Outcomes in Women With Inflammatory Bowel Syndrome Following Exposure to Thiopurines and Anti-Tumor Necrosis Factor Drugs: A Meta-Analysis and Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Systematic Review and Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Infliximab (Anti–Tumor Necrosis Factor Α Antibody)
Archives of Dermatology
Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Frontiers in Pharmacology
Pharmacology
